Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15075694 | 0.68 | LMNA (0.38) | LMNAADORA2BADORA2AADORA1 | |
| SCHEMBL15384357 | 0.61 | LMNA (0.37) | LMNAADORA2BADORA2AADORA1 | |
| SCHEMBL9597539 | 0.59 | ADORA2A (0.37) | LMNAADORA2BADORA2AADORA1 | |
| SCHEMBL19611492 | 0.57 | FDPS (0.47) | LMNAADORA2BADORA2AADORA1 | |
| SCHEMBL15075700 | 0.55 | LMNA (0.38) | LMNAADORA2BADORA2AADORA1 | |
| SCHEMBL15384250 | 0.54 | LMNA (0.36) | LMNAADORA2BADORA2AADORA1 | |
| SCHEMBL440676 | 0.54 | — | — | |
| SCHEMBL17895776 | 0.54 | NPSR1 (0.51) | LMNAADORA2BADORA2AADORA1 | |
| SCHEMBL9597264 | 0.53 | TRPM5 (0.44) | LMNAADORA2AADORA1 | |
| Hydrochloric Acid SCHEMBL15436961 | 0.53 | KMT2A (0.60) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130165427-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES | HYDRA BIOSCIENCES, INC. (US) | 2013-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165427-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES | ELANE, CASP3, MMP8 | LMNA 594/4885ADORA2B 1599/4885ADORA2A 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.